Saunders Scott J
SEC Form 4 insider trading activity
Saunders Scott J has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Saunders Scott J is listed as Director at Nutex Health Inc. Inside the rolling window, Saunders Scott J reported no open-market purchases and 1 open-market sale totaling $43K in NUTX.
Companies traded
Other insiders at NUTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$43K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Saunders Scott J made?
Saunders Scott J has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Saunders Scott J trade?
Saunders Scott J has filed SEC Form 4 disclosures for 1 company, including NUTX.
When was Saunders Scott J's most recent SEC Form 4 filing?
Saunders Scott J's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Saunders Scott J's total buy and sell value in the current window?
Inside the rolling retention window, Saunders Scott J bought $0 and sold $43K based on SEC Form 4 filings.
What was Saunders Scott J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 203 NUTX shares on 2026-09-18, worth $43K, per SEC Form 4 filings.